{
  "id": 13249897,
  "title": "Women with PMOS should get subsidised weight loss drugs, advocates say",
  "url": "https://urgent.news/2026/10/09/women-with-pmos-should-get-subsidised-weight-loss-drugs-advocates-say",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-09T23:00:41.000Z",
  "source": {
    "name": "The Guardian",
    "slug": "the-guardian",
    "url": "https://www.theguardian.com/australia-news/2026/oct/10/women-with-pmos-should-get-subsidised-weight-loss-drugs-advocates-say"
  },
  "original_language": "en",
  "account": null,
  "summary": "With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-label Get our breaking news email , free app or daily news podcast Women living with a chronic hormonal condition should have access to taxpayer-funded weight loss medications, advocates say. The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Guardian Australia",
        "title": "Women with PMOS should get subsidised weight loss drugs, advocates say",
        "url": "https://urgent.news/2026/10/09/women-with-pmos-should-get-subsidised-weight-loss-drugs-advocates-say-13251195",
        "published": "2026-10-09T23:00:41.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}